Defective presentation of endogenous antigen by a cell line expressing class I molecules.
about
Up-regulation of HLA class-I antigen expression and antigen-specific CTL response in cervical cancer cells by the demethylating agent hydralazine and the histone deacetylase inhibitor valproic acidPresentation of numerous viral peptides to mouse major histocompatibility complex (MHC) class I-restricted T lymphocytes is mediated by the human MHC-encoded transporter or by a hybrid mouse-human transporterTwo putative subunits of a peptide pump encoded in the human major histocompatibility complex class II regionIdentification of human cancers deficient in antigen processingThe transporter associated with antigen processing: function and implications in human diseasesMemory immune responses against pandemic (H1N1) 2009 influenza virus induced by a whole particle vaccine in cynomolgus monkeys carrying Mafa-A1*052:02Detection of rare antigen-presenting cells by the lacZ T-cell activation assay suggests an expression cloning strategy for T-cell antigens.Epigenetic priming restores the HLA class-I antigen processing machinery expression in Merkel cell carcinomaThe effects of tolerance on allograft damage caused by the innate immune systemStability screening of arrays of major histocompatibility complexes on combinatorially encoded flow cytometry beads.Getting the inside out: the transporter associated with antigen processing (TAP) and the presentation of viral antigenAn analogue peptide from the Cancer/Testis antigen PASD1 induces CD8+ T cell responses against naturally processed peptide.T cell receptor interactions with class I heavy-chain influence T cell selection.A novel zinc finger gene, ZNF465, is inappropriately expressed in acute myeloid leukaemia cells.Identification of Four-Jointed Box 1 (FJX1)-Specific Peptides for Immunotherapy of Nasopharyngeal Carcinoma.Defective presentation of endogenous antigens by a murine sarcoma. Implications for the failure of an anti-tumor immune responseStability of empty and peptide-loaded class II major histocompatibility complex molecules at neutral and endosomal pH: comparison to class I proteins.Recognition of vaccinia virus-encoded major histocompatibility complex class I antigens by virus immune cytotoxic T cells is independent of the polymorphism of the peptide transporters.Endogenously synthesized peptide with an endoplasmic reticulum signal sequence sensitizes antigen processing mutant cells to class I-restricted cell-mediated lysis.Alloreactive cytotoxic T lymphocytes recognize epitopes determined by both the alpha helices and beta sheets of the class I peptide binding site.An endogenous antigenic peptide bypasses the class I antigen presentation defect in RMA-SExtracellular processing of peptide antigens that bind class I major histocompatibility moleculesEfficient dissociation of the p88 chaperone from major histocompatibility complex class I molecules requires both beta 2-microglobulin and peptide.Peptide-induced stabilization and intracellular localization of empty HLA class I complexes.Measles virus transmembrane fusion protein synthesized de novo or presented in immunostimulating complexes is endogenously processed for HLA class I- and class II-restricted cytotoxic T cell recognition.Expression of HLA-B27 in transgenic mice is dependent on the mouse H-2D genesLoss of transporter protein, encoded by the TAP-1 gene, is highly correlated with loss of HLA expression in cervical carcinomas.Conformational differences in major histocompatibility complex-peptide complexes can result in alloreactivity.Peptide length and sequence specificity of the mouse TAP1/TAP2 translocatorDownregulation of peptide transporter genes in cell lines transformed with the highly oncogenic adenovirus 12.Naturally processed viral peptides recognized by cytotoxic T lymphocytes on cells chronically infected by human immunodeficiency virus type 1Species-specific differences in chaperone interaction of human and mouse major histocompatibility complex class I molecules.Expression of HLA-C molecules confers target cell resistance to some non-major histocompatibility complex-restricted T cells in a manner analogous to allospecific natural killer cells.Two novel routes of transporter associated with antigen processing (TAP)-independent major histocompatibility complex class I antigen processing.Carfilzomib enhances natural killer cell-mediated lysis of myeloma linked with decreasing expression of HLA class I.Alloantibodies can discriminate class I major histocompatibility complex molecules associated with various endogenous peptidesRecognition of neuroectodermal tumors by melanoma-specific cytotoxic T lymphocytes: evidence for antigen sharing by tumors derived from the neural crestParticipation of a novel 88-kD protein in the biogenesis of murine class I histocompatibility molecules.Driving adenovirus type 12-transformed BALB/c mouse cells to express high levels of class I major histocompatibility complex proteins enhances, rather than abrogates, their tumorigenicityTrafficking of spontaneously endocytosed MHC proteins.
P2860
Q24288944-E4EEDBBC-6A3D-4185-9B1D-8DD08DA6F5CCQ24336610-05F97665-7828-49D3-85C4-627C997BBA3DQ24560017-DA599837-65DC-47F0-A87A-60CFA2AC4C4DQ24678495-965C4D3F-7884-4A1B-B302-874690239B37Q28214433-73F5F86E-33DA-4AEF-B65B-3162980DCBC9Q30417157-54C304BE-21CE-4A1B-8E81-13B07054F3CFQ30990189-8C0D8DA3-9E7D-43B2-A40D-D769317341B3Q33720183-B526C812-C54D-4800-8353-FBE7409ECA64Q33757956-6C6D934E-B69D-484E-9CE4-8EB261B70C73Q33934932-EE787CF8-92E8-49F5-9BDF-C2D4C9ABD72DQ34754320-607015F9-F0F5-4A4B-8FFD-E78F7416C91EQ34862104-1E6C3641-725B-4F71-A696-0F535D676B59Q34976927-530BEE33-1A4B-4FE6-A0C6-7C496A384922Q35565945-859031AC-F836-4230-9E58-C7E02FD09BC5Q35832185-B2BDFAD6-E442-4A09-B4B4-982D078CE625Q35945199-6BBB9471-48E9-4F3D-9594-1B2C313D386EQ36048493-733383B1-AB05-4629-AADD-773903B5FCDDQ36191749-696870B9-1165-4296-858F-304C497D031DQ36230273-4E024B2E-6DF4-4CB7-809F-9DCE43A05746Q36230989-C704CF49-8B21-41A4-AE4C-3D1A4016D6DEQ36231070-0ABAF3F1-731A-4F2D-AB67-6E107939F543Q36231285-D8C22BFD-85A7-4528-B40B-9EEB7B6B1688Q36231365-5FD8B134-1720-481C-AFC2-ECED2F4051DAQ36231485-8680A442-EFD1-4528-BF3B-1A325167D4F0Q36231571-2389F08F-6C68-4652-B3DE-D03789DD0CB6Q36353664-2574C460-F47C-48C9-A0AC-958D586DA731Q36362670-4D01C733-1684-4ADF-B94A-07A5C6FB0E4EQ36362680-C04C6C8A-9164-43F6-AD1B-EC0A17793C8AQ36362717-0D6F3279-8908-43B4-BBBB-83EE580CCE5FQ36363521-12BD4791-9060-4AEF-B2F5-1F2FF7B83929Q36363763-79C732A1-CEF7-4611-BD6D-BD80EC03B182Q36364251-6AD2A0A8-464D-4953-94B5-D6FEE4DE4280Q36365713-280C7CA4-A337-41E1-BBB5-911839E317D1Q36380657-43ADB808-FE8A-4D02-8CC4-A70C5D179901Q36413676-E0840482-50EF-4701-B2C8-1C8D8B6F5A89Q36441789-56058027-C10F-4AAE-BAAA-6BC115CBCCD6Q36470250-00D3B5D0-D9AC-4383-9FD4-44BD4BDD4580Q36529404-059DD246-6081-4BBE-8E8D-89E55D64A940Q36697378-53E44E09-863E-43B5-B616-DF363B49F796Q36703975-29FE6A3D-A6C1-4D5F-BF4F-4D7BC348D733
P2860
Defective presentation of endogenous antigen by a cell line expressing class I molecules.
description
1990 nî lūn-bûn
@nan
1990年の論文
@ja
1990年論文
@yue
1990年論文
@zh-hant
1990年論文
@zh-hk
1990年論文
@zh-mo
1990年論文
@zh-tw
1990年论文
@wuu
1990年论文
@zh
1990年论文
@zh-cn
name
Defective presentation of endogenous antigen by a cell line expressing class I molecules.
@en
type
label
Defective presentation of endogenous antigen by a cell line expressing class I molecules.
@en
prefLabel
Defective presentation of endogenous antigen by a cell line expressing class I molecules.
@en
P356
P1433
P1476
Defective presentation of endogenous antigen by a cell line expressing class I molecules.
@en
P2093
P304
P356
10.1126/SCIENCE.2326647
P407
P577
1990-04-01T00:00:00Z